Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.
Accent Microcell's operating assets for the quarter that ended in Mar. 2025 was ₹1,774 Mil. Accent Microcell's operating liabilities for the quarter that ended in Mar. 2025 was ₹321 Mil. Accent Microcell's Total Assets for the quarter that ended in Mar. 2024 was ₹2,048 Mil. Therefore, Accent Microcell's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2025 was 0.71.
Accent Microcell Scaled Net Operating Assets Related Terms
Accent Microcell Scaled Net Operating Assets Historical Data
* Premium members only.
The historical data trend for Accent Microcell's Scaled Net Operating Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accent Microcell Scaled Net Operating Assets Chart
Accent Microcell Annual Data
Trend
Mar21
Mar22
Mar23
Mar24
Mar25
Scaled Net Operating Assets
0.69
0.66
0.75
0.94
0.71
Accent Microcell Semi-Annual Data
Mar21
Mar22
Mar23
Mar24
Mar25
Scaled Net Operating Assets
0.69
0.66
0.75
0.94
0.71
NSE:ACCENTMIC vs ZTS, UTHR: Scaled Net Operating Assets Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Accent Microcell's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accent Microcell Scaled Net Operating Assets vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Accent Microcell's Scaled Net Operating Assets distribution charts can be found below:
* The bar in red indicates where Accent Microcell's Scaled Net Operating Assets falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Scaled Net Operating Assets of 0.71 mean?
Accent Microcell (NSE:ACCENTMIC) has a Scaled Net Operating Assets of 0.71 as of Mar. 2025. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Accent Microcell and its competitors.
Is Accent Microcell's Scaled Net Operating Assets too high?
Accent Microcell's current Scaled Net Operating Assets is 0.71. Overall, Accent Microcell has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Accent Microcell's Scaled Net Operating Assets compare to ZTS and UTHR?
Accent Microcell's Scaled Net Operating Assets of 0.71 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Drug Manufacturers company?
A good Scaled Net Operating Assets depends on the Drug Manufacturers industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Accent Microcell and its competitors. Accent Microcell's current Scaled Net Operating Assets is 0.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accent Microcell stock overvalued right now?
Accent Microcell (NSE:ACCENTMIC) has a current Scaled Net Operating Assets of 0.71. The current Scaled Net Operating Assets is 0.71. Accent Microcell's overall GF Score™ is 19/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Accent Microcell (NSE:ACCENTMIC), the current Scaled Net Operating Assets is 0.71 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Accent Microcell Ltd is engaged in the manufacturing business of pharmaceutical excipients including products like Microcrystalline Cellulose which is a term for refined wood pulp and is used as a texturizer, an anti-caking agent, a fat substitute, an emulsifier, an extender, and a bulking agent in food production; Croscarmellose Sodium used as a super disintegrant in pharmaceutical formulations; Magnesium Stearate; Cellulose Powder, and others. Its business segments are segregated based on the location of its manufacturing facilities and include Dahej (SEZ Unit), Pirana, Unit III, and Inter Unit Sales. Geographically, a majority of the company's revenue is derived through the export of its products to various countries.
19GF Score
Get the complete analysis for NSE:ACCENTMIC
Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ACCENTMIC has been successfully added to your 
